Tumor angiogenesis

New England Journal of Medicine

Volumn 359, Issue 7, 2008, Pages 763-764

  Zerbini, Gianpaolo ^a   Lorenzi, Mara ^b   Palini, Alessio ^a  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD133 ANTIGEN; CD34 ANTIBODY; VASCULOTROPIN RECEPTOR 2;

ANGIOGENESIS; CARCINOGENESIS; CELL POPULATION; ENDOTHELIUM CELL; FLOW CYTOMETRY; HUMAN; LETTER; PRIORITY JOURNAL; STEM CELL;

ANTIGENS, CD; ANTIGENS, CD45; ENDOTHELIAL CELLS; GLYCOPROTEINS; HUMANS; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; PEPTIDES; STEM CELLS; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

EID: 49449110955     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc081278     Document Type: Letter

References (2)

1. Kerbel RS. Tumor angiogenesis. N Engl J Med 2008;358:2039-49.
2. Bertolini F, Shaked Y, Mancuso P, Kerbel RS. The multifaceted circulating endothelial cell in cancer: towards marker and target identification. Nat Rev Cancer 2006;6:835-45.